Home › Acute Lymphoblastic Leukemia › South Carolina › Greenville
Acute Lymphoblastic Leukemia clinical trials in Greenville, SC
3 studies for Acute Lymphoblastic Leukemia are looking for participants at sites in and around Greenville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Prisma Health Cancer Institute - Faris, Greenville
- Prisma Health Greenville Memorial Hospital, Greenville
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RecruitingPhase 1/2
- BI-LO Charities Children's Cancer Center, Greenville
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
RecruitingObservational study
- BI-LO Charities Children's Cancer Center, Greenville
Acute Lymphoblastic Leukemia trials in other cities
- Houston, TX28 studies
- New York City, NY23 studies
- Baldwin Park, CA21 studies
- Seattle, WA21 studies
- Chicago, IL20 studies
- Atlanta, GA19 studies
- Memphis, TN16 studies
- Washington, DC16 studies
- Philadelphia, PA16 studies
- Boston, MA15 studies
- Los Angeles, CA14 studies
- Mountain View, CA13 studies
Other studies in Greenville
- Non-Small Cell Lung Cancer15 studies
- Breast Cancer12 studies
- Acute Myeloid Leukemia10 studies
- Cancer (all types)9 studies
- Obesity9 studies
- Lung Cancer9 studies
- Overweight8 studies
- Prostate Cancer7 studies
- Colorectal Cancer7 studies
- Stomach Cancer6 studies
- Peripheral Arterial Disease5 studies
- Burkitt Lymphoma5 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.